Literature DB >> 26558196

The protective role of tacrine and donepezil in the retina of acetylcholinesterase knockout mice.

Yun-Min Yi1, Li Cai2, Yi Shao3, Man Xu2, Jing-Lin Yi1.   

Abstract

AIM: To determine the effect of different concentrations of the acetylcholinesterase (AChE) inhibitors tacrine and donepezil on retinal protection in AChE(+/-) mice (AChE knockout mice) of various ages.
METHODS: Cultured ARPE-19 cells were treated with hydrogen peroxide (H2O2) at concentrations of 0, 250, 500, 1000 and 2000 µmol/L and protein levels were measured using Western blot. Intraperitoneal injections of tacrine and donepezil (0.1 mg/mL, 0.2 mg/mL and 0.4 mg/mL) were respectively given to AChE(+/-) mice aged 2mo and 4mo and wild-type S129 mice for 7d; phosphate buffered saline (PBS) was administered to the control group. The mice were sacrificed after 30d by in vitro cardiac perfusion and retinal samples were taken. AChE-deficient mice were identified by polymerase chain reaction (PCR) analysis using specific genotyping protocols obtained from the Jackson Laboratory website. H&E staining, immunofluorescence and Western blot were performed to observe AChE protein expression changes in the retinal pigment epithelial (RPE) cell layer.
RESULTS: Different concentrations of H2O2 induced AChE expression during RPE cell apoptosis. AChE(+/-) mice retina were thinner than those in wild-type mice (P<0.05); the retinal structure was still intact at 2mo but became thinner with increasing age (P<0.05); furthermore, AChE(+/-) mice developed more slowly than wild-type mice (P<0.05). Increased concentrations of tacrine and donepezil did not significantly improve the protection of the retina function and morphology (P>0.05).
CONCLUSION: In vivo, tacrine and donepezil can inhibit the expression of AChE; the decrease of AChE expression in the retina is beneficial for the development of the retina.

Entities:  

Keywords:  AChE+/− animal models; acetylcholinesterase; acetylcholinesterase inhibitors; apoptosis; retinal pigment epithelium

Year:  2015        PMID: 26558196      PMCID: PMC4631000          DOI: 10.3980/j.issn.2222-3959.2015.05.06

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.779


  29 in total

1.  Acetylcholine modulates the immune response in Zhikong scallop Chlamys farreri.

Authors:  Xiaowei Shi; Lingling Wang; Zhi Zhou; Rui Liu; Yunchen Li; Linsheng Song
Journal:  Fish Shellfish Immunol       Date:  2014-03-26       Impact factor: 4.581

2.  (+/-)-huprine Y, (-)-huperzine A and tacrine do not show neuroprotective properties in an apoptotic model of neuronal cytoskeletal alteration.

Authors:  E G Jordá; E Verdaguer; A Jiménez; A M Canudas; V Rimbau; P Camps; D Muñoz-Torrero; A Camins; M Pallàs
Journal:  J Alzheimers Dis       Date:  2004-12       Impact factor: 4.472

3.  Drastic decrease in dopamine receptor levels in the striatum of acetylcholinesterase knock-out mouse.

Authors:  Anna Hrabovska; Vladimir Farar; Veronique Bernard; Ellen G Duysen; Jiri Brabec; Oksana Lockridge; Jaromir Myslivecek
Journal:  Chem Biol Interact       Date:  2010-01-05       Impact factor: 5.192

Review 4.  The key role of butyrylcholinesterase during neurogenesis and neural disorders: an antisense-5'butyrylcholinesterase-DNA study.

Authors:  A Mack; A Robitzki
Journal:  Prog Neurobiol       Date:  2000-04       Impact factor: 11.685

5.  Acetylcholinesterase function in apoptotic retina pigment epithelial cells induced by H2O2.

Authors:  Li Cai; Hong-Fei Liao; Xue-Jun Zhang; Yi Shao; Man Xu; Jing-Lin Yi
Journal:  Int J Ophthalmol       Date:  2013-12-18       Impact factor: 1.779

6.  Cancer-associated differences in acetylcholinesterase activity in bronchial aspirates from patients with lung cancer.

Authors:  Ana Martínez-López de Castro; Susana Nieto-Cerón; Pons-Castillo Aurelio; Lilian Galbis-Martínez; Juan Latour-Pérez; Juan Torres-Lanzas; Isabel Tovar-Zapata; Pedro Martínez-Hernández; José Neptuno Rodríguez-López; Juan Cabezas-Herrera
Journal:  Clin Sci (Lond)       Date:  2008-10       Impact factor: 6.124

7.  BZYX, a novel acetylcholinesterase inhibitor, significantly improved chemicals-induced learning and memory impairments on rodents and protected PC12 cells from apoptosis induced by hydrogen peroxide.

Authors:  Jing Zhang; Difeng Zhu; Rong Sheng; Honghai Wu; Yongzhou Hu; Feng Wang; Tianyu Cai; Bo Yang; Qiaojun He
Journal:  Eur J Pharmacol       Date:  2009-04-01       Impact factor: 4.432

8.  Muscarinic receptor knockout mice confirm involvement of M3 receptor in endothelium-dependent vasodilatation in mouse arteries.

Authors:  Jean-Louis Bény; Minh Ngoc Nguyen; Mathieu Marino; Minoru Matsui
Journal:  J Cardiovasc Pharmacol       Date:  2008-05       Impact factor: 3.105

Review 9.  Should I stay or should I go? Trafficking of sub-lytic MAC in the retinal pigment epithelium.

Authors:  Aparna Lakkaraju; Kimberly A Toops; Jin Xu
Journal:  Adv Exp Med Biol       Date:  2014       Impact factor: 2.622

10.  Bacopa monnieri ameliorates memory deficits in olfactory bulbectomized mice: possible involvement of glutamatergic and cholinergic systems.

Authors:  Xoan Thi Le; Hang Thi Nguyet Pham; Phuong Thi Do; Hironori Fujiwara; Ken Tanaka; Feng Li; Tai Van Nguyen; Khoi Minh Nguyen; Kinzo Matsumoto
Journal:  Neurochem Res       Date:  2013-08-15       Impact factor: 3.996

View more
  2 in total

Review 1.  Beta-amyloid sequelae in the eye: a critical review on its diagnostic significance and clinical relevance in Alzheimer's disease.

Authors:  T M Shah; S M Gupta; P Chatterjee; M Campbell; R N Martins
Journal:  Mol Psychiatry       Date:  2017-01-17       Impact factor: 15.992

Review 2.  Tacrine Derivatives in Neurological Disorders: Focus on Molecular Mechanisms and Neurotherapeutic Potential.

Authors:  Saikat Mitra; Maniza Muni; Nusrat Jahan Shawon; Rajib Das; Talha Bin Emran; Rohit Sharma; Deepak Chandran; Fahadul Islam; Md Jamal Hossain; Sher Zaman Safi; Sherouk Hussein Sweilam
Journal:  Oxid Med Cell Longev       Date:  2022-08-18       Impact factor: 7.310

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.